Intravenous cyclophosphamide therapy in a case with refractory thrombotic microangiopathic hemolytic anemia and SLE

Clinical Rheumatology

Volumn 23, Issue 6, 2004, Pages 541-543

  Akaogi, Jun ^a   Akasaka, Noriko ^a   Yamada, Hidehiro ^a   Hama, Nobuaki ^a   Satoh, Minoru ^b   Nichols, Cody ^b   Ozaki, Shoichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Anti platelet antibodies; Cyclophosphamide; Systemic lupus erythematosus; Thrombotic microangiopathic hemolytic anemia

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G ANTIBODY; PREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HISTIOCYTOSIS; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; PLASMAPHERESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE AGGREGATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANEMIA, HEMOLYTIC; ANTIRHEUMATIC AGENTS; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; THROMBOSIS; TREATMENT OUTCOME;

EID: 9444254705     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0939-y     Document Type: Article

References (10)

1. Liu J, Hutzler M, Li C, et al. (2001) Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): The new thinking. J Thromb Thrombolysis 11:261-272 10.1023/A:101191122595, 1:STN:280:DC%BD3MrjtVGmtA%3D%3D, 11577265
2. Allford SL, Hunt BJ, Rose P, et al. (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 120:556-573 10.1046/j.1365-2141.2003.04049.x, 12588343
3. Porta C, Caporali R, Montecucco C (1999) Thrombotic thrombocytopenic purpura and autoimmunity: A tale of shadows and suspects. Haematologica 84:260-269 1:STN:280:DyaK1M3hvVWlsg%3D%3D, 10189393
4. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589-600
5. Caramaschi P, Riccetti MM, Pasini AF, et al. (1998) Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature. Lupus 7:37-41 10.1191/096120398678919705, 1:STN:280:DyaK1c7lsVWruw%3D%3D, 9493147
6. Vasoo S, Thumboo J, Fong KY (2002) Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: Disease activity and the use of cytotoxic drugs. Lupus 11:443-450 10.1191/0961203302lu224oa, 1:STN:280:DC%2BD38vjvVartg%3D%3D, 12195786
7. Musio F, Bohen EM, Yuan CM, et al. (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 28:1-19 1:STN:280:DyaK1czpt12gsA%3D%3D, 9726331
8. Rock GA (2000) Management of thrombotic thrombocytopenic purpura. Br J Haematol 109:496-507 10.1046/j.1365-2141.2000.01941.x, 1:STN:280:DC%2BD3czksFequw%3D%3D, 10886194
9. Perez-Sanchez I, Anguita J, Pintado T (1999) Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: Report of two cases. Ann Hematol 78:285-287 10.1007/s002770050516, 1:STN:280:DyaK1MzkvFCqtg%3D%3D, 10422632
10. Allan DS, Kovacs MJ, Clark WF (2001) Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy. Haematologica 86:844-850 1:STN:280:DC%2BD3MvnvFWjuw%3D%3D, 11522541